Search results - 7 results

papillomavirus (HPV) vaccine (Cervarix, GSK, Rixensart, Belgium) (1). The study completes and strengthens the evidence of the high level of effectiveness of primary cervical cancer prevention by HPV vaccination ...

a group of experts to develop the third edition of European Guidelines for Quality Assurance of Cervical Cancer prevention based on integrated HPV vaccination and screening and to monitor the progress ...

estimates for 2018, approximately 33 000 cases of cervical cancer occurred and 15 000 people died from the disease in Europe (see map in appendix). Human papillomavirus (HPV) vaccine coverage is relatively ...

populations, and 4) consideration of the broader spectrum of cancers and other diseases preventable by HPV vaccination in women, as well as in men. Despite the huge advances already achieved, there must be ...

triage policies. This article forms part of a special supplement entitled “Comprehensive Control of HPV Infections and Related Diseases” Vaccine Volume 30, Supplement 5, 2012. Health Topics:  Quality of ...

the evidence and potential practice recommendations regarding primary and secondary prevention and treatment of cancers and other disease associated with HPV infection. HPV infection causes ~600,000 ...

Keywords: clinical efficacy immunogenicity prophylactic HPV vaccines Abstract: This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the immunogenicity, ...